Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept

Autoimmunity Reviews

Volumn 8, Issue 1, 2008, Pages 76-82

  Fiocco, Ugo ^a   Sfriso, Paolo ^a   Oliviero, Francesca ^a   Pagnin, Elisa ^a   Scagliori, Elena ^a   Campana, Carla ^a   Dainese, Serena ^a   Cozzi, Luisella ^a   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Abatacept co stimulatory modulation; Cell contact activation; Rheumatoid arthritis; T regulatory cells

Indexed keywords

ABATACEPT; CAVEOLIN 1; CHEMOKINE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; FC RECEPTOR; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MEMBRANE; DENDRITIC CELL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE GENE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; OXIDATIVE STRESS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVITIS; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 54549119268     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.035     Document Type: Review

References (40)

1. Goronzy J.J., and Weyand C.M. Rheumatoid arthritis. Immunol Rev 204 (2005) 55-73
2. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in > 4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77 (2005) 1044-1060
3. Maier L.M., Anderson D.E., De Jager P.L., Wicker L.S., and Hafler D.A. Allelic variant in CTLA4 alters T cell phosphorylation patterns. Proc Natl Acad Sci U S A 104 (2007) 18607-18612
4. Rueda B., Oliver J., Robledo G., López-Nevot M.A., Balsa A., Pascual-Salcedo D., et al. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum 56 (2007) 3953-3958
5. Brusko T.M., Wasserfall C.H., Agarwal A., Kapturczak M.H., and Atkinson M.A. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol 174 (2005)
6. Liston A., Lesage S., Gray D.H., Boyd R.L., and Goodnow C.C. Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol Rev 204 (2005) 87-101
7. Cope A.P., Schulze-Koops H., and Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 25 5 Suppl 46 (2007) S4-11
8. Raza K., Falciani F., Curnow S.J., Ross E.J., Lee C.Y., Akbar A.N., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7 (2005) R784-795
9. Ponchel F., Morgan A.W., Bingham S.J., Quinn M., Buch M., Verburg R.J., et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 100 (2002) 4550-4556
10. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
11. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203 (2006) 2673-2682
12. Michel J.J., Turesson C., Lemster B., Atkins S.R., Iclozan C., Bongartz T., et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis Rheum 56 (2007) 43-57
13. Lacraz S., Isler P., Vey E., Welgus H.G., and Dayer J.M. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 269 (1994) 22027-22033
14. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis? II. T Cell-independent mechanisms from beginning to end. Arthritis Rheum 46 (2002) 298-308
15. Brennan F.M., Hayes A.L., Ciesielski C.J., Green P., Foxwell B.M., and Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum 46 (2002) 31-41
16. Burger D., and Dayer J.M. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res 4 Suppl 3 (2002) S169-176
17. van Roon J.A., Verweij M.C., Wijk M.W., Jacobs K.M., Bijlsma J.W., and Lafeber F.P. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum 52 (2005) 1700-1710
18. Ohnuma K., Inoue H., Uchiyama M., Yamochi T., Hosono O., Dang N.H., et al. T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol 16 (2006) 3-13
19. Vallejo A.N., Yang H., Klimiuk P.A., Weyand C.M., and Goronzy J.J. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol 171 (2003) 1732-1740
20. Clark J., Vagenas P., Panesar M., and Cope A.P. What does tumour necrosis factor excess do to the immune system long term?. Ann Rheum Dis 64 Suppl 4 (2005) iv70-iv76
21. Alegre M.L., and Fallarino F. Mechanisms of CTLA4-Ig in tolerance induction. Curr Pharm Des 12 (2006) 149-160
22. Sharpe A.H., and Abbas A.K. T-cell costimulation-biology, therapeutic potential, and challenges. N Engl J Med 355 (2006) 973-975
23. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
24. Gough S.C., Walker L.S., and Sansom D.M. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204 (2005) 102-115
25. Mahnke K., Bedke T., and Enk A.H. Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression. Cell Immunol 250 (2007) 1-13
26. Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., et al. Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17 (2006) 58-60
27. Li R., Perez N., Karumuthil-Melethil S., Prabhakar B.S., Holterman M.J., and Vasu C. Enhanced engagement of CTLA4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells. J Immunol 179 (2007) 5191-5203
28. Vincenti F. Co-stimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 121 (2008) 299-306
29. Haggerty H.G., Abbott M.A., Reilly T.P., DeVona D.A., Gleason C.R., Tay L., et al. Evaluation of immunogenicity of the T cell co-stimulation modulator abatacept in patients treated for rheumatoid arthritis. J Rheumatol 34 (2007) 2365-2373
30. Fallarino F., Bianchi R., Orabona C., Vacca C., Belladonna M.L., Fioretti M.C., et al. CTLA4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 200 (2004) 1051-1062
31. Pae H.O., Oh G.S., Choi B.M., Chae S.C., Kim Y.M., Chung K.R., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172 (2004) 4744-4751
32. + regulatory T cells. International Immunology 20 (2007) 471-483
33. Axmann R., Herman S., Zaiss M., Franz S., Polzer K., Zwerina J., et al. CTLA4 directly inhibits osteoclast formation. Ann Rheum Dis (Jan 18 2008) [Electonic publication ahead of print]
34. Remans P.H., Wijbrandts C.A., Sanders M.E., Toes R.E., Breedveld F.C., Tak P.P., et al. CTLA4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells. Arthritis Rheum 54 (2006) 3135-3143
35. Ling S., Lai A., Borschukova O., Pumpens P., and Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum 54 (2006) 3423-3432
36. van Amelsfort J.M., van Roon J.A., Noordegraaf M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., and Taams L.S. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56 (2007) 732-742
37. Zaiss M.M., Axmann R., Zwerina J., Polzer K., Gückel E., Skapenko A., et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 56 (2007) 4104-4112
38. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., et al. Foxp3 inhibits RORgamma t-mediated IL-17A mRNA transcription through direct interaction with RORgamma t. Biol Chem 283 (2008) 17003-17008
39. Nistala K., Moncrieffe H., Newton K.R., Varsani H., Hunter P., and Wedderburn L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58 (2008) 875-887
40. Todd D.J., Costenbader K.H., and Weinblatt M.E. Abatacept in the treatment of rheumatoid arthritis. Int J Clin Pract 61 (2007) 494-500